Liberia

SCI DEVELOPMENT NET                                                                                April 29, 2015
(includes links to five feature stories and editorials on communication issues and other subjects.)
The outbreak of Ebola that has affected West Africa since December 2013 is the largest to date, with enormous human and economic costs. It has also exposed weaknesses in the global response system, including the handling of communication and complex social responses. What can we learn from this to better manage future health emergencies?

This Spotlight presents an in-depth analysis including opinions, facts and figures, and key resources. It features commentary by Sylvie Briand of the WHO, Rosamund Southgate of Médecins Sans Frontières and Annie Wilkinson of the Institute of Development Studies. 

It includes first-hand accounts by researchers with experience in the field, and interviews with social science expert Melissa Leach and communications managers at Médecins Sans Frontières-UK and BBC Media Action.
Read complete articles.

ASSOCIATED PRESS by Maria Cheng                                                        April 28, 2015

LONDON — The World Health Organization says it aims to identify and isolate all new Ebola cases in West Africa by the end of May to stop the spread of the lethal virus before the rainy season.

In a new Ebola plan released on Tuesday, the U.N. health agency said it hopes to limit transmission of the virus to the coastal areas of Guinea, Liberia and Sierra Leone before the rainy season begins, normally in April or May.

WHO said the decline in Ebola's spread has "plateaued," partly due to "persistently high transmission" in Guinea and Sierra Leone. Officials say the rainy season will make it more difficult for responders to reach remote areas....

BUSINESS STANDARD                                                                        April 27, 2015

HYDERABAD, India --Ella Foundation, which has taken up research for finding a potential vaccine for the deadly Ebola virus, today said it had successfully completed preliminary studies on the virus, which was responsible for high fatalities among humans in central Africa.

The Hyderabad-based foundation said it had completed the preliminary animal (with mice) experiments of the virus' glycoprotein with the targeted adenovirus, and the "immune response results have been good", which would be followed by toxicology tests and the subsequent clinical trials involving human beings.

Adenoviruses are responsible for respiratory infections, gastroenteritis, cystitis, and primary pneumonia in humans, and are therefore used as a clear target to understand the human immunity characteristics in laboratory. However, the efficacy of the vaccine is judged by the outcomes seen in human trials.

Read complete story.

http://www.business-standard.com/article/current-affairs/ella-foundation-announces-key-outcomes-in-ebola-vaccine-research-115042700631_1.html

AFP    by Zoom Dosso                                                            April 24, 2015
Monrovia -- As the Ebola epidemic retreats across west Africa, international health authorities are turning their attention to the little understood long-term effects of the often-deadly virus on the survivors.

Matshidiso Moeti, the WHO's new head in Africa, told AFP that Liberian survivors had been reporting a range of problems, including sight and hearing impairment.

"We need to be aware that (complications) may be occurring and pay attention when people are being treated in case there is something that can be done to help them," she told AFP in the Liberian capital Monrovia.

Read complete story.

http://news.yahoo.com/west-africa-battles-mystery-post-ebola-syndrome-034727521.html;_ylt=AwrC0CM1rDtVtDoA83rQtDMD;_ylu=X3oDMTByOHZyb21tBGNvbG8DYmYxBHBvcwMxBHZ0aWQDBHNlYwNzcg--